BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 29069651)

  • 1. Staphylococcus aureus α-Toxin Induces Inflammatory Cytokines via Lysosomal Acid Sphingomyelinase and Ceramides.
    Ma J; Gulbins E; Edwards MJ; Caldwell CC; Fraunholz M; Becker KA
    Cell Physiol Biochem; 2017; 43(6):2170-2184. PubMed ID: 29069651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide.
    Becker KA; Fahsel B; Kemper H; Mayeres J; Li C; Wilker B; Keitsch S; Soddemann M; Sehl C; Kohnen M; Edwards MJ; Grassmé H; Caldwell CC; Seitz A; Fraunholz M; Gulbins E
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29084896
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages.
    Rozenova KA; Deevska GM; Karakashian AA; Nikolova-Karakashian MN
    J Biol Chem; 2010 Jul; 285(27):21103-13. PubMed ID: 20236926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid sphingomyelinase-derived ceramide is not required for inflammatory cytokine signalling in murine macrophages.
    Manthey CL; Schuchman EH
    Cytokine; 1998 Sep; 10(9):654-61. PubMed ID: 9770326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis.
    Taniguchi M; Ogiso H; Takeuchi T; Kitatani K; Umehara H; Okazaki T
    Cell Death Dis; 2015 Apr; 6(4):e1717. PubMed ID: 25855965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal α-toxin-induced keratinocyte death.
    Brauweiler AM; Bin L; Kim BE; Oyoshi MK; Geha RS; Goleva E; Leung DY
    J Allergy Clin Immunol; 2013 Feb; 131(2):421-7.e1-2. PubMed ID: 23246020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal β-Toxin Modulates Human Aortic Endothelial Cell and Platelet Function through Sphingomyelinase and Biofilm Ligase Activities.
    Herrera A; Kulhankova K; Sonkar VK; Dayal S; Klingelhutz AJ; Salgado-Pabón W; Schlievert PM
    mBio; 2017 Mar; 8(2):. PubMed ID: 28325766
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of the inflammasome by ceramide in cystic fibrosis lungs.
    Grassmé H; Carpinteiro A; Edwards MJ; Gulbins E; Becker KA
    Cell Physiol Biochem; 2014; 34(1):45-55. PubMed ID: 24977480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
    Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
    J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus β-Toxin Mutants Are Defective in Biofilm Ligase and Sphingomyelinase Activity, and Causation of Infective Endocarditis and Sepsis.
    Herrera A; Vu BG; Stach CS; Merriman JA; Horswill AR; Salgado-Pabón W; Schlievert PM
    Biochemistry; 2016 May; 55(17):2510-7. PubMed ID: 27015018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis.
    Peng H; Li C; Kadow S; Henry BD; Steinmann J; Becker KA; Riehle A; Beckmann N; Wilker B; Li PL; Pritts T; Edwards MJ; Zhang Y; Gulbins E; Grassmé H
    J Mol Med (Berl); 2015 Jun; 93(6):675-89. PubMed ID: 25616357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.
    Craven RR; Gao X; Allen IC; Gris D; Bubeck Wardenburg J; McElvania-Tekippe E; Ting JP; Duncan JA
    PLoS One; 2009 Oct; 4(10):e7446. PubMed ID: 19826485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases.
    Lopez-Castejon G; Theaker J; Pelegrin P; Clifton AD; Braddock M; Surprenant A
    J Immunol; 2010 Aug; 185(4):2611-9. PubMed ID: 20639492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia.
    Terada K; Yamada J; Hayashi Y; Wu Z; Uchiyama Y; Peters C; Nakanishi H
    Glia; 2010 Jan; 58(1):114-24. PubMed ID: 19544382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation.
    Jenkins RW; Canals D; Idkowiak-Baldys J; Simbari F; Roddy P; Perry DM; Kitatani K; Luberto C; Hannun YA
    J Biol Chem; 2010 Nov; 285(46):35706-18. PubMed ID: 20807762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells.
    Liu F; Li X; Lu C; Bai A; Bielawski J; Bielawska A; Marshall B; Schoenlein PV; Lebedyeva IO; Liu K
    Oncotarget; 2016 Dec; 7(51):83907-83925. PubMed ID: 27880732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal ceramide mediates gemcitabine-induced death of glioma cells.
    Dumitru CA; Sandalcioglu IE; Wagner M; Weller M; Gulbins E
    J Mol Med (Berl); 2009 Nov; 87(11):1123-32. PubMed ID: 19763526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin D targeted by acid sphingomyelinase-derived ceramide.
    Heinrich M; Wickel M; Schneider-Brachert W; Sandberg C; Gahr J; Schwandner R; Weber T; Saftig P; Peters C; Brunner J; Krönke M; Schütze S
    EMBO J; 1999 Oct; 18(19):5252-63. PubMed ID: 10508159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internalization of
    Nagahama M; Kobayashi K; Ochi S; Takehara M
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33918753
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics.
    Murray JM; Thompson AM; Vitsky A; Hawes M; Chuang WL; Pacheco J; Wilson S; McPherson JM; Thurberg BL; Karey KP; Andrews L
    Mol Genet Metab; 2015 Feb; 114(2):217-25. PubMed ID: 25092414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.